Decline in ARSB and the resulting increase in chondroitin 4-sulfate have been investigated in a wide range of neurological disorders, including spinal cord injury, peripheral nerve injury, optic nerve injury, traumatic brain injury, and Alzheimer’s Disease. The gene discussed is ARSB; the disease is Alzheimer disease.